Stem Cells Spin S.A. (WSE:SCS)
0.3880
+0.0080 (2.11%)
At close: Jun 3, 2026
Stem Cells Spin Revenue
Stem Cells Spin had revenue of 7.38K PLN in the quarter ending March 31, 2026, a decrease of -7.03%. This brings the company's revenue in the last twelve months to 65.18K, up 12.50% year-over-year. In the year 2025, Stem Cells Spin had annual revenue of 65.74K with 21.11% growth.
Revenue (ttm)
65.18K
Revenue Growth
+12.50%
P/S Ratio
247.34
Revenue / Employee
65.18K
Employees
1
Market Cap
16.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 65.74K | 11.46K | 21.11% |
| Dec 31, 2024 | 54.28K | -365.04K | -87.06% |
| Dec 31, 2023 | 419.32K | 170.96K | 68.84% |
| Dec 31, 2022 | 248.36K | -277.56K | -52.78% |
| Dec 31, 2021 | 525.92K | 257.60K | 96.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.83B |
| Diagnostyka | 2.51B |
| Synektik Spólka Akcyjna | 706.45M |
| Voxel | 583.79M |
| genXone | 2.34M |
| InventionMed | 2.28M |
| Airway Medix | 89.00K |
| Medicofarma Biotech | 43.90K |